We updated the design of this site on September 25th. Learn more.

Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.

Verified August 2004 by National Taiwan University Hospital.
Recruitment status was: Recruiting

Sponsor:

ClinicalTrials.gov Identifier:

NCT00173316

First Posted: September 15, 2005

Last Update Posted: December 9, 2005

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

Information provided by:

National Taiwan University Hospital

Purpose

The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions

Condition
Oral Cancer


Study Type:	Observational
Study Design:	Observational Model: Defined Population Primary Purpose: Screening Time Perspective: Longitudinal Time Perspective: Retrospective
Official Title:	The Role of Vascular Endothelial Growth Factor-C (VEGF-C) and Its Receptors Induced Lymphangiogenesis on the Carcinogenesis of Oral Cancers and Premalignant Lesions

Resource links provided by NLM:

MedlinePlus related topics: Oral Cancer

Genetic and Rare Diseases Information Center resources: Oral Cancer Lip and Oral Cavity Cancer

U.S. FDA Resources

Further study details as provided by National Taiwan University Hospital:


Estimated Enrollment:	80
Study Start Date:	August 2004
Estimated Study Completion Date:	June 2005

Detailed Description:

The role of vascular endothelial growth factor-C (VEGF-C) and its receptors induced lymphangiogenesis and host inflammatory responses on the carcinogenesis of oral cancers and premalignant lesions

Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:	18 Years to 85 Years (Adult, Senior)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

oral cancer and oral precancer specimens

Exclusion Criteria:

other diseases

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00173316

Contacts


Contact: Chun-Pin Chiang, DMSc	886-2-23123456 ext 6855	cpchiang@ha.mc.ntu.edu.tw

Locations


Taiwan
National Taiwan university	Recruiting
Taipei, Taiwan, 100
Principal Investigator: Chun-Pin Chiang, DMSc

Sponsors and Collaborators

National Taiwan University Hospital

Investigators


Principal Investigator:	Chun-Pin Chiang, DMSc	National Taiwan University

More Information


ClinicalTrials.gov Identifier:	NCT00173316 History of Changes
Other Study ID Numbers:	9461700614
First Submitted:	September 12, 2005
First Posted:	September 15, 2005
Last Update Posted:	December 9, 2005
Last Verified:	August 2004

Keywords provided by National Taiwan University Hospital:


vascular endothelial growth factor-C VEGF-CR lymphangiogenesis host inflammatory responses	oral carcinogenesis oral cancers oral premalignant lesions

Additional relevant MeSH terms:


Mouth Neoplasms Lip Neoplasms Precancerous Conditions Carcinogenesis Head and Neck Neoplasms Neoplasms by Site Neoplasms Mouth Diseases	Stomatognathic Diseases Lip Diseases Neoplastic Processes Pathologic Processes Endothelial Growth Factors Growth Substances Physiological Effects of Drugs

To Top